PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 5, 2014, Pages 532-539

  Shen, J ^a   Wong, G L H ^a   Chan, H L Y ^a   Chan, H Y ^a   Yeung, D K W ^a   Chan, R S M ^a   Chim, A M L ^a   Chan, A W H ^a   Choi, P C L ^a   Woo, J ^a   Chu, W C W ^a   Wong, V W S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DIET; FATTY LIVER; FEMALE; HUMANS; LIPASE; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84893760888     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12609     Document Type: Article

References (47)

1. Williams CD, Stengel J, Asike MI, et al,. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
2. Wong VW, Chu WC, Wong GL, et al,. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-15.
3. Ascha MS, Hanouneh IA, Lopez R, et al,. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-8.
4. Wong VW, Wong GL, Choi PC, et al,. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74.
5. Romeo S, Kozlitina J, Xing C, et al,. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5.
6. Yuan X, Waterworth D, Perry JR, et al,. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008; 83: 520-8.
7. Speliotes EK, Yerges-Armstrong LM, Wu J, et al,. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7: e1001324.
8. Kantartzis K, Peter A, Machicao F, et al,. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009; 58: 2616-23.
9. Peng XE, Wu YL, Lin SW, et al,. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS ONE 2012; 7: e50256.
10. Santoro N, Kursawe R, D'Adamo E, et al,. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 2010; 52: 1281-90.
11. Hyysalo J, Stojkovic I, Kotronen A, et al,. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2012; 27: 951-6.
12. Kawaguchi T, Sumida Y, Umemura A, et al,. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 2012; 7: e38322.
13. Petta S, Grimaudo S, Camma C, et al,. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J Hepatol 2012; 56: 1356-62.
14. Rotman Y, Koh C, Zmuda JM, et al,. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
15. Speliotes EK, Butler JL, Palmer CD, et al,. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-12.
16. Valenti L, Alisi A, Galmozzi E, et al,. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1274-80.
17. Valenti L, Al-Serri A, Daly AK, et al,. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-17.
18. Zain SM, Mohamed R, Mahadeva S, et al,. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum Genet 2012; 131: 1145-52.
19. Hoekstra M, Li Z, Kruijt JK, et al,. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 2010; 52: 244-51.
20. He S, McPhaul C, Li JZ, et al,. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-15.
21. Perttila J, Huaman-Samanez C, Caron S, et al,. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am J Physiol Endocrinol Metab 2012; 302: E1063-9.
22. Pirazzi C, Adiels M, Burza MA, et al,. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol 2012; 57: 1276-82.
23. Kumashiro N, Yoshimura T, Cantley JL, et al,. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology 2013; 57: 1763-72.
24. Valenti L, Rametta R, Ruscica M, et al,. The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. BMC Gastroenterol 2012; 12: 111.
25. Wong VW, Hui AY, Tsang SW, et al,. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 1154-61.
26. Davis JN, Le KA, Walker RW, et al,. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010; 92: 1522-7.
27. Santoro N, Savoye M, Kim G, et al,. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS ONE 2012; 7: e37827.
28. Wong VW, Wong GL, Chu WC, et al,. Hepatitis B virus infection and fatty liver in the general population. J Hepatol 2012; 56: 533-40.
29. Woo J, Leung SSF, Ho SC, et al,. A food frequency questionnaire for use in the Chinese population in Hong Kong: description and examination of validity. Nutrition Research 1997; 17: 1633-41.
30. Willett WC, Howe GR, Kushi LH,. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-8S.
31. Alberti KG, Eckel RH, Grundy SM, et al,. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
32. Wong VW, Wong GL, Tsang SW, et al,. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-36.
33. Wong VW, Vergniol J, Wong GL, et al,. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.
34. Li Y, Xing C, Cohen JC, et al,. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology 2012; 55: 327-8.
35. Sookoian S, Pirola CJ,. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-94.
36. Goran MI, Walker R, Le KA, et al,. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 2010; 59: 3127-30.
37. Wagenknecht LE, Palmer ND, Bowden DW, et al,. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011; 31: 412-6.
38. Lin YC, Chang PF, Hu FC, et al,. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr 2011; 158: 740-4.
39. Ferolla SM, Ferrari TC, Lima ML, et al,. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo) 2013; 68: 11-7.
40. Papandreou D, Karabouta Z, Pantoleon A, et al,. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. Appetite 2012; 59: 939-44.
41. Musso G, Gambino R, De Michieli F, et al,. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-16.
42. Mouzaki M, Allard JP,. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46: 457-67.
43. Sevastianova K, Kotronen A, Gastaldelli A, et al,. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr 2011; 94: 104-11.
44. Valenti L, Rumi M, Galmozzi E, et al,. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 2011; 53: 791-9.
45. Stickel F, Buch S, Lau K, et al,. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011; 53: 86-95.
46. Nischalke HD, Berger C, Luda C, et al,. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS ONE 2011; 6: e27087.
47. Guyot E, Sutton A, Rufat P, et al,. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J Hepatol 2013; 58: 312-8.